Evidence map›Paper›PMID 30611645›Full record

ReviewUrologic oncology2020

Urologic conditions associated with malignancy.

Eric M Lo, James M Hotaling, Alexander W Pastuszak

Open access · greenAbstract readReview
In one paragraph

Review in Urologic oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Eric M LoBaylor College of Medicine, Houston, TX.
James M HotalingDivision of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT.
Alexander W PastuszakDivision of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT. Electronic address: alexander.pastuszak@hsc.utah.edu.
University of Utah · USBaylor College of Medicine · US

Funding

Characterization of the Role of NELL1 in the Predisposition to Peyronie's and Dupuytren's Diseases.K08DK115835 · NIDDK · UNIVERSITY OF UTAH · PI PASTUSZAK, ALEXANDER WOJCIECH · 2018 to 2020
$490k
NIDDK NIH HHS K08 DK115835
6 · The paper itself

Abstract

introductionRecent advances in cancer research have highlighted the role of genetics in malignancy. Genetic dysregulation of core cellular functions similarly influences benign conditions. These common genetic factors have led researchers to identify an association between certain urologic conditions and malignancy. The objective of this review is to evaluate the literature linking benign urologic conditions including male infertility, Peyronie's disease, cryptorchidism, and hypospadias, to malignancy.

methodsA search of PubMed was performed using the following search terms and their combinations: male infertility, female infertility, cancer, malignancy, mortality, male urologic conditions, azoospermia, Peyronie's disease, cryptorchidism, hypospadias, and genetics. Studies were assessed for quality and included or excluded based on study design and relevance to the topic of urologic conditions and malignancy.

resultsA total of 52 studies were evaluated, of which 38 were included. Associations between male infertility and testicular cancer, prostate cancer, and other cancers including melanoma, bladder cancer, and thyroid cancer were examined. Several genetic alterations were found to be common in the pathogenesis of both male infertility and carcinogenesis. Associations between female infertility and breast, ovarian, and endometrial cancer are also assessed, as are the relationships between Peyronie's disease, cryptorchidism, and hypospadias and malignancy.

conclusionsRecent work has identified associations between a number of malignancies and benign urologic conditions including male infertility, Peyronie's disease, cryptorchidism, and hypospadias. Molecular and genetic mechanisms have been proposed, but no definitive causal relationships have been identified to date. Future work will continue to better define the links between malignancy and benign urologic conditions and ultimately facilitate risk stratification, screening, and treatment of affected men.

Indexed as

HumansInfertility, MaleMalePenile IndurationRisk FactorsTesticular NeoplasmsUrologic DiseasesUrologic NeoplasmsCryptorchidismHypospadiasMale infertilityPeyronie's diseaseProstate cancerTesticular cancer

Identifiers

PMID30611645
PMCPMC6606400
OpenAlexW2907252862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.